FAK Inhibition Emerges as a Potential Complementary Treatment Pathway
Although FAK inhibition alone has displayed modest activity to date, there is interest in developing FAK-targeted therapies for combination regimens.
New York United States West Palm Beach Memorial Sloan Kettering Cancer Center Racheln Grisham Asia Pacific
Source: onclive.com